Ajdler Arnaud 4
4 · Recro Pharma, Inc. · Filed Dec 9, 2019
Insider Transaction Report
Form 4
Ajdler Arnaud
Director
Transactions
- Award
Common Stock
2019-12-05+7,439→ 15,394 total
Holdings
- 1,104,546(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the "Company") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued service with the Company.
- [F2]The Reporting Person is the managing partner of Engine Capital Management, LP ("Engine Management") and the Managing Member of each of Engine Capital Management GP, LLC ("Engine Management GP") and Engine Investments, LLC ("Engine Investments"). Engine Management GP is the investment manager of Engine Capital, L.P. ("Engine Capital") and Engine Jet Capital, L.P. ("Engine Jet Capital"). Engine Capital and Engine Jet Capital own 907,578 and 196,968 shares of the Issuer's common stock, respectively. The Reporting Person disclaims beneficial ownership in such securities except to the extent of his pecuniary interest therein.